Table 1.
Number and incidence (%) of individuals who develop R2 (preproliferative retinopathy), R3A (active proliferative retinopathy), M1 (diabetic maculopathy) or any of R2, R3A or M1, split up by sex and type of diabetes
| Type I | Type II | |||
|---|---|---|---|---|
| Men (%) | 252 (51.9) | 5211 (56.6) | ||
| Total (%) | 486 (5.0) | 9201 (95.0) | ||
| annual | biennial | annual | biennial | |
| Men | ||||
| Developed R2 (%) | 22 (8.7) | 35 (13.9) | 69 (1.3) | 110 (2.1) |
| Developed R3A (%) | 15 (6.0) | 17 (6.7) | 25 (0.5) | 45 (0.9) |
| Developed M1 (%) | 23 (9.1) | 36 (14.3) | 114 (2.2) | 216 (4.1) |
| Developed any above (%) | 41 (16.3) | 52 (20.6) | 153 (2.9) | 259 (5.0) |
| Women | ||||
| Developed R2 (%) | 15 (6.4) | 23 (9.8) | 32 (0.8) | 56 (1.4) |
| Developed R3A (%) | 11 (4.7) | 14 (6.0) | 9 (0.2) | 14 (0.4) |
| Developed M1 (%) | 17 (7.3) | 31 (13.2) | 89 (2.2) | 153 (3.8) |
| Developed any above (%) | 30 (12.8) | 41 (17.5) | 107 (2.7) | 179 (4.5) |
The results are shown for annual incidence (1 year) and biennial incidence (2 years).